Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Léger

Showing results (31-40 of 2,166) with videos related to

Pageof 217
Sort By:
Journal of Public Health (Oxford, England)|December 18, 2025
AI regulatory strategies: a global public health perspectiveNicholas Léger-Riopel
FEBS Letters|May 3, 1993
Monoclonal antibodies targeted against the C-terminal domain of dystrophin or utrophinE Fabbrizio, J Léger, M Anoal, et al.
European Heart Journal|December 1, 1984
Characterization and distribution of myosin variants in normal and pathological human heartsJ Léger, C Dechesne, P Bouvagnet, et al.
International Journal of Cancer|September 1, 1994
The chondroitin sulfate proteoglycan NG2 is a tumour-specific antigen on the chemically induced rat chondrosarcoma HSNO Léger, C Johnson-Léger, E Jackson, et al.
Acta Haematologica|January 1, 1980
The reproducibility of two methods of studying granulopoiesis: agar culture and labelling indexD Seigneurin, J Léger
Dialogues in Clinical Neuroscience|February 16, 2011
Brain serotonergic circuitriesYves Charnay, Lucienne Léger
Angewandte Chemie (International Ed. in English)|March 17, 2017
Dinitrogen Reduction: Interfacing the Enzyme Nitrogenase with ElectrodesVincent Fourmond, Christophe Léger
Chirurgie De La Main|March 10, 2005
[Carpal tunnel syndrome revealed by digital ulcerations caused by arterial vasospasm]O Léger, F Lavallé
Annales De Cardiologie Et D'Angeiologie|February 1, 1992
[Development of diagnosis and treatment of arterial diseases over the course of time]P Léger, H Boccalon
Archives Des Maladies Du Coeur Et Des Vaisseaux|April 19, 2006
From molecular to modular cardiology. How to interpret the millions of data that came out from large scale analysis of gene expression?J Léger, B Swynghedauw
Pageof 217

Showing results (31-40 of 2,166) with videos related to

Sort By:
Pageof 217
Journal of Public Health (Oxford, England)|December 18, 2025
AI regulatory strategies: a global public health perspectiveNicholas Léger-Riopel
FEBS Letters|May 3, 1993
Monoclonal antibodies targeted against the C-terminal domain of dystrophin or utrophinE Fabbrizio, J Léger, M Anoal, et al.
European Heart Journal|December 1, 1984
Characterization and distribution of myosin variants in normal and pathological human heartsJ Léger, C Dechesne, P Bouvagnet, et al.
International Journal of Cancer|September 1, 1994
The chondroitin sulfate proteoglycan NG2 is a tumour-specific antigen on the chemically induced rat chondrosarcoma HSNO Léger, C Johnson-Léger, E Jackson, et al.
Acta Haematologica|January 1, 1980
The reproducibility of two methods of studying granulopoiesis: agar culture and labelling indexD Seigneurin, J Léger
Dialogues in Clinical Neuroscience|February 16, 2011
Brain serotonergic circuitriesYves Charnay, Lucienne Léger
Angewandte Chemie (International Ed. in English)|March 17, 2017
Dinitrogen Reduction: Interfacing the Enzyme Nitrogenase with ElectrodesVincent Fourmond, Christophe Léger
Chirurgie De La Main|March 10, 2005
[Carpal tunnel syndrome revealed by digital ulcerations caused by arterial vasospasm]O Léger, F Lavallé
Annales De Cardiologie Et D'Angeiologie|February 1, 1992
[Development of diagnosis and treatment of arterial diseases over the course of time]P Léger, H Boccalon
Archives Des Maladies Du Coeur Et Des Vaisseaux|April 19, 2006
From molecular to modular cardiology. How to interpret the millions of data that came out from large scale analysis of gene expression?J Léger, B Swynghedauw
Pageof 217